Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00161720 · ClinicalTrials.gov registry record
Retrospective Study to Capture Dosing and Treatment Outcome Data in Participants With Severe Congenital Protein C Deficiency Who Were Treated With Protein C Concentrate Under an Emergency Use IND
A clinical trial, sponsored by Baxalta now part of Shire.
- Completed
- Registry status
- 11
- Enrollment target
NCT00161720 is a clinical trial that has completed, run by Baxalta now part of Shire. The registered enrollment target is 11 participants.
The verdict
NCT00161720 has completed, sponsored by Baxalta now part of Shire.
- COMPLETED
- Registry status
- 11 participants
- Enrollment target
Study Summary
This is a data collection study with the purpose of capturing dosing and treatment outcome data in participants with severe congenital protein C deficiency who were treated with protein C concentrate under an Emergency Use Investigational New Drug Application (IND).
Interventions
- DRUG Protein C Concentrate (Human) Vapor Heated
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2005-06-01 |
| Est. Completion | 2005-12-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00161720
The ClinicalTrials.gov registry entry for NCT00161720 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 11 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Baxalta now part of Shire, which has 74 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Protein C Concentrate (Human) Vapor Heated is the first listed.
NCT00161720 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00161720 about?
NCT00161720 is a clinical study titled "Retrospective Study to Capture Dosing and Treatment Outcome Data in Participants With Severe Congenital Protein C Deficiency Who Were Treated With Protein C Concentrate Under an Emergency Use IND". This is a data collection study with the purpose of capturing dosing and treatment outcome data in participants with severe congenital protein C deficiency who were treated with protein C concentrate under an Emergency Use Investigational New Drug Application (IND).
What is the current status of trial NCT00161720?
This trial is currently completed. The enrollment target is 11 participants. The study started on 2005-06-01. Estimated completion is 2005-12-01.
What interventions are being tested in trial NCT00161720?
The interventions under investigation include: Protein C Concentrate (Human) Vapor Heated (DRUG).
Who is sponsoring clinical trial NCT00161720?
This trial is sponsored by Baxalta now part of Shire, which has 74 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.